Molecular Interactions – Assay Kits
Homogeneous Mix-and-Measure Assay Kits for Cancer Immunotherapy
Biochemical High-Throughput Screening of Cancer Immunotherapy Drug Candidates
Activity of Tryptophan-Metabolizing Enzymes Using NFK Green™ -GreenScreen™
Fluorescence Assay for the Evaluation of Human and Mouse IDO1 and TDO Activity
Catalog No.
|
Datapoints | Cell-based | Biochemical | Contents |
---|---|---|---|---|
NTRC-GSCell-1K | 1,000 | Probe; substrate; IDO1 and TDO reference inhibitors | ||
NTRC-GSCell-10K | 10,000 | idem | ||
NTRC-hIDO-1K | 1,000 | Probe; substrate; assay buffer; human IDO1 protein; IDO1 reference inhibitor | ||
NTRC-hIDO-10K | 10,000 | idem | ||
NTRC-mIDO-1K | 1,000 | Probe; substrate; assay buffer; mouse IDO1 protein; IDO1 reference inhibitor | ||
NTRC-hTDO-1K | 1,000 | Probe; substrate; assay buffer; human TDO protein; TDO reference inhibitor | ||
NTRC-hTDO-10K | 10,000 | idem | ||
NTRC-mTDO-1K | 1,000 | Probe; substrate; assay buffer; mouse TDO protein; TDO reference inhibitor |
Key Features |
NFK Green™ |
---|---|
Mild reaction conditions | |
Ambient temperature | |
Neutral pH | |
Homogeneous assay format | |
HTS compatible | |
End-point measurements | |
Fluorescent readout |
Tryptophan metabolism plays an important role in immune modulation and neurodegenerative disease. Tryptophan-metabolizing enzymes are drug targets for cancer immunotherapy and neurodegenerative disease. We have developed NFK Green™ assays for the high-throughput screening of the tryptophan-metabolizing enzymes indoleamine 2,3-dioxygenase (IDO1) and tryptophan dioxygenase (TDO). The NFK Green™ assay works under mild conditions and is suitable for high-throughput screening. The fluorescence assay is based on a highly specific and unique label, developed by NTRC, named NFK Green™. The protocol allows a rapid implementation of the assay for high-throughput screening or regular compound testing.
References
Seegers et al. (2014) High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes. Journal of Biomolecular Screening, 19 (9):1266-1274.